FGFR3IIIS: a novel soluble FGFR3 spliced variant that modulates growth is frequently expressed in tumour cells

Sturla, L-M, Merrick, AE and Burchill, SA (2003) FGFR3IIIS: a novel soluble FGFR3 spliced variant that modulates growth is frequently expressed in tumour cells. British Journal of Cancer, 89 (7). pp. 1276-1284. ISSN 0007-0920

Abstract

Metadata

Authors/Creators:
  • Sturla, L-M
  • Merrick, AE
  • Burchill, SA
Copyright, Publisher and Additional Information: © 2003 Cancer Research UK. From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
Keywords: FGFR3IIIS; FGFR3IIIc; splice variant; tumours; soluble protein; dominant negative
Dates:
  • Published: 30 September 2003
  • Accepted: 8 July 2003
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > Institute of Molecular Medicine (LIMM) (Leeds) > Section of Experimental Oncology (Leeds)
The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Cancer and Pathology (LICAP) > Section of Experimental Oncology (Leeds)

The University of Leeds > Faculty of Medicine and Health (Leeds) > Institute of Molecular Medicine (LIMM) (Leeds) > Section of Oncology and Clinical Research (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 14 Jul 2016 11:49
Last Modified: 11 Apr 2018 12:35
Published Version: http://dx.doi.org/10.1038/sj.bjc.6601249
Status: Published
Publisher: Cancer Research UK
Identification Number: https://doi.org/10.1038/sj.bjc.6601249

Share / Export

Statistics